Dec 9 (Reuters) - Eli Lilly said on Tuesday it will invest more than $6 billion in a new active drug ingredient manufacturing facility in Huntsville, Alabama, to expand U.S. production and bolster medicine supply chains.
The site, the third new U.S. facility announced by Lilly, will make small-molecule synthetic and peptide medicines, including orforglipron, its first oral GLP-1 weight-loss drug anticipated to receive U.S. approval early next year.
Global pharmaceutical companies have been increasing U.S. investments after President Donald Trump urged the industry to make more medicines domestically rather than importing active ingredients or finished medicines.
Earlier this year, Lilly outlined plans to spend at least $27 billion on four new U.S. manufacturing sites to counter potential drug import duties. Lilly said another location will be announced in the coming weeks.
The company said the construction is slated to begin in 2026, creating about 3,000 construction jobs, with completion targeted for 2032. Lilly also plans 450 roles for engineers, scientists, operations personnel and lab technicians in the area.
CEO David Ricks said the investment advances the onshoring of active pharmaceutical ingredient production to strengthen supply resilience.
The company estimates every dollar invested could generate up to four dollars in local economic activity.
The site was chosen from more than 300 applications, aided by proximity to the HudsonAlpha Institute for Biotechnology, an established bioscience campus supporting workforce training and research, Lilly said.
Alabama Governor Kay Ivey called the project "the largest initial investment in our state's history."
Lilly said the plant will use machine learning, AI and digitally integrated monitoring systems, with automation embedded across operations.
The company also aims to work toward carbon neutrality at the site, said Edgardo Hernandez, Lilly's manufacturing operations head.
(Reporting by Puyaan Singh in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Like many holiday traditions, lighting candles and fireplaces is best done in moderation - 2Moscow accuses Berlin of stifling the opposition
- 3CDC advisory panel delays vote on hepatitis B vaccines after unruly meeting
- 4The most effective method to Apply Antiquated Ways of thinking in Current Brain science Practices
- 5Bomb blast in packed Nigerian mosque kills five
- First part of major new German-Danish tunnel cleared for lowering
- German finance minister seeks better market access in China talks
- Untamed life Safe-havens All over the Planet Offering Remarkable Creature Experiences
- Midlife weight gain can start long before menopause – but you can take steps early on to help your body weather the hormonal shift
- Everything you should know before booking a trip to Spain
- Make your choice for a definitive Christmas place to get-away!
- Cases of norovirus are on the rise just in time for the holiday season
- I’m a dad to an autistic child. Here’s how you can make the holidays easier for all of us.
- Poland Crypto Bill Clears Sejm Again, Defying President — Will “Restrictive” Rules Stick?
